{"created_at":"Fri Jun 06 15:15:57 +0000 2014","id":474932714676957184,"id_str":"474932714676957184","text":"RT @FiercePharma: Top-read on FP Thurs: AbbVie readies production in anticipation of hep C treatment approval http:\/\/t.co\/BeyaCDn9Of $ABBV \u2026","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":271111167,"id_str":"271111167","name":"AdverseEvents","screen_name":"AdverseEvent","location":"Santa Rosa, CA","url":"http:\/\/www.adverseevents.com","description":"AdverseEvents makes drug safety information accessible, actionable, and predictable.","protected":false,"verified":false,"followers_count":847,"friends_count":634,"listed_count":36,"favourites_count":291,"statuses_count":1374,"created_at":"Wed Mar 23 21:49:30 +0000 2011","utc_offset":-25200,"time_zone":"Pacific Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"ACCCE0","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/440868029488836608\/aBkTGDKG.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/440868029488836608\/aBkTGDKG.png","profile_background_tile":true,"profile_link_color":"CE7834","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"78C0A8","profile_text_color":"5E412F","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/439518283885068289\/u4NQUHDC_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/439518283885068289\/u4NQUHDC_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/271111167\/1398374706","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Jun 06 12:24:09 +0000 2014","id":474889478268411905,"id_str":"474889478268411905","text":"Top-read on FP Thurs: AbbVie readies production in anticipation of hep C treatment approval http:\/\/t.co\/BeyaCDn9Of $ABBV #pharma","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294275,"id_str":"18294275","name":"FiercePharma","screen_name":"FiercePharma","location":"West End, District of Columbia","url":"http:\/\/www.fiercepharma.com","description":"FiercePharma's 140, written by Tracy Staton. Join 90,000 pharma insiders on our free newsletter at http:\/\/FiercePharma.com.","protected":false,"verified":false,"followers_count":29585,"friends_count":450,"listed_count":1011,"favourites_count":8,"statuses_count":13934,"created_at":"Sun Dec 21 22:25:49 +0000 2008","utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"060932","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DA490B","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDFFCC","profile_text_color":"080707","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":6,"favorite_count":2,"entities":{"hashtags":[{"text":"pharma","indices":[121,128]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/BeyaCDn9Of","expanded_url":"http:\/\/www.fiercepharma.com\/story\/abbvie-readies-production-anticipation-hep-c-treatment-approval\/2014-06-05","display_url":"fiercepharma.com\/story\/abbvie-r\u2026","indices":[92,114]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[115,120]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[139,140]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/BeyaCDn9Of","expanded_url":"http:\/\/www.fiercepharma.com\/story\/abbvie-readies-production-anticipation-hep-c-treatment-approval\/2014-06-05","display_url":"fiercepharma.com\/story\/abbvie-r\u2026","indices":[110,132]}],"user_mentions":[{"screen_name":"FiercePharma","name":"FiercePharma","id":18294275,"id_str":"18294275","indices":[3,16]}],"symbols":[{"text":"ABBV","indices":[133,138]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Fri Jun 06 11:55:51 +0000 2014","id":474882357887901697,"id_str":"474882357887901697","text":"Are you thinking of Investing in $ABBV $NCR $MSFT  $USD #Stock http:\/\/t.co\/Yc7of8rRoi","source":"\u003ca href=\"https:\/\/mobile.twitter.com\" rel=\"nofollow\"\u003eMobile Web (M2)\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2469211321,"id_str":"2469211321","name":"Hunakai Goodhand","screen_name":"mixezujybys","location":"Liverpool","url":null,"description":"ialist .Incurable music nerd  ...","protected":false,"verified":false,"followers_count":6,"friends_count":5,"listed_count":0,"favourites_count":0,"statuses_count":204,"created_at":"Tue Apr 29 12:13:20 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"DBE9ED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme17\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme17\/bg.gif","profile_background_tile":false,"profile_link_color":"CC3366","profile_sidebar_border_color":"DBE9ED","profile_sidebar_fill_color":"E6F6F9","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/463705075915833344\/dFf4jpRF_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/463705075915833344\/dFf4jpRF_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"Stock","indices":[56,62]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/Yc7of8rRoi","expanded_url":"http:\/\/bit.ly\/1kGrmq1","display_url":"bit.ly\/1kGrmq1","indices":[63,85]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[33,38]},{"text":"NCR","indices":[39,43]},{"text":"MSFT","indices":[44,49]},{"text":"USD","indices":[51,55]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Thu Jun 05 22:30:42 +0000 2014","id":474679735260160000,"id_str":"474679735260160000","text":"$ABBV The Zacks Analyst Blog Highlights: Pharmacyclics, AbbVie, Gilead, Amgen and Celgene. http:\/\/t.co\/8FJmGGr9Vr","source":"\u003ca href=\"http:\/\/dlvr.it\" rel=\"nofollow\"\u003edlvr.it\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2344020043,"id_str":"2344020043","name":"Brad Williams","screen_name":"ABradWilliams","location":"US","url":null,"description":"Investor","protected":false,"verified":false,"followers_count":17,"friends_count":53,"listed_count":0,"favourites_count":0,"statuses_count":68,"created_at":"Fri Feb 14 19:25:24 +0000 2014","utc_offset":-10800,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"0099B9","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme4\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme4\/bg.gif","profile_background_tile":false,"profile_link_color":"0099B9","profile_sidebar_border_color":"5ED4DC","profile_sidebar_fill_color":"95E8EC","profile_text_color":"3C3940","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/460331329322627073\/J1ciGa24_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/460331329322627073\/J1ciGa24_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/8FJmGGr9Vr","expanded_url":"http:\/\/top10stocks2buy.com\/i.php?http:\/\/finance.yahoo.com\/news\/zacks-analyst-blog-highlights-pharmacyclics-113616756.html&t6t=ABBV","display_url":"top10stocks2buy.com\/i.php?http:\/\/f\u2026","indices":[91,113]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
